Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. BIOS.US

BioPlus Acquisition Corp (BIOS NASDAQ) stock market data APIs

10.795 0(0%) as of October 13, 2023

BioPlus Acquisition Corp Financial Data Overview

10.795
10.795
0
10.795
10.795
0 - 0
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Get BioPlus Acquisition Corp Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get BioPlus Acquisition Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BioPlus Acquisition Corp latest news via APIs

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have mutually agreed to terminate their previously announced business combination agreement and...
  • AVERTIXMEDICAL
  • BIOPLUS ACQUISITION CORP
  • BUSINESSCOMBINATION
  • MERGERS AND ACQUISITIONS
  • NASDAQ:BIOSU
  • PRESS RELEASES
  • SPAC

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived on...
  • AVERTIX MEDICAL INC
  • MANAGEMENT STATEMENTS
Do you have any questions?
support@eodhistoricaldata.com